🔎 Trials Near Me

Akèy › Dyabèt Tip 2 › Texas › San Antonio

Etid klinik pou Dyabèt Tip 2 nan San Antonio, TX

37 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote San Antonio (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Ap rekriteFaz 3
  • NE Clin Res of San Antonio, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Ap rekriteFaz 3
  • IMA Clinical Research San Antonio, San Antonio
  • Pinnacle Clinical Research, LLC, San Antonio
  • University of Texas Health Science Center at San Antonio, San Antonio
  • ak 3 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Ap rekriteFaz 3
  • Pinnacle Clinical Research - San Antonio, San Antonio
  • Pinnacle Clinical Research, LLC, San Antonio
  • Consano Clinical Research, Shavano Park · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07754461

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Ap rekriteFaz 1
  • Endeavor Clinical Trials, San Antonio
Laj 18 a 65 · Tout sèks · Mizajou Sep 28, 2026 · NCT07399678

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Ap rekriteFaz 3
  • VIP Trials, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Ap rekriteFaz 3
  • IMA Clinical Research San Antonio, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Ap rekriteFaz 3
  • Research Site, San Antonio
  • Research Site, San Antonio
  • Research Site, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

Ap rekriteVolontè an sante akeyi
  • The University of Texas Health Science Center at San Antonio, San Antonio
Laj 18 a 65 · Tout sèks · Mizajou Sep 22, 2026 · NCT02969798

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3
  • AURORA-2 Clinical Site, San Antonio
  • AURORA-2 Clinical Site, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Ap rekriteFaz 2
  • AES - DRS - Synexus Clinical Research US, Inc. - San Antonio, San Antonio
  • Flourish Research - San Antonio - PPDS, San Antonio
Laj 18 a 75 · Tout sèks · Mizajou Sep 15, 2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Ap rekriteFaz 3
  • Pinnacle Clinical Research - San Antonio, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Ap rekriteFaz 2
  • Consano Clinical Research, LLC, Shavano Park · 12 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT06897475

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Ap rekriteFaz 2
  • Consano Clinical Research, LLC, Shavano Park · 12 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 11, 2026 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Ap rekriteFaz 2
  • Clinical Advancement Center, San Antonio
  • University of Texas Health - San Antonio, San Antonio
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

Ap rekriteFaz 2
  • Quality Research Inc, San Antonio
  • Tekton Research Inc, San Antonio
  • Consano Clin Res-Shavano Park, Shavano Park · 12 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 11, 2026 · NCT07668388

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Ap rekriteFaz 3
  • Research Site, San Antonio
  • Research Site, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07662213

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Ap rekriteFaz 2
  • Diabetes & Glandular Disease Clinic, P.A., San Antonio
  • Texas Valley Clinical Research - San Antonio TX, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

Ap rekriteFaz 3
  • Consano Clinical Research, LLC, Shavano Park · 12 mi lwen
Laj 10 a 18 · Tout sèks · Mizajou Sep 9, 2026 · NCT07282613

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Ap rekriteFaz 2
  • Consano Clinical Research, LLC, Shavano Park · 12 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT07215559

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Ap rekriteFaz 3
  • Clinical Advancement Center, San Antonio
  • The IMA Group IMA Clinical Trials of America Inc. CTA, San Antonio
  • Univ Of Texas Hlth Science Cntr, San Antonio
  • ak 2 plis
Laj 45 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Ap rekriteFaz 3
  • Research Site, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07662109

Quantifying Hepatic Mitochondrial Fluxes in Humans

Ap rekriteFaz 4
  • Texas Diabetes Institute - University Health System, San Antonio
  • University of Texas Health Science Center at San Antonio, San Antonio
Laj 18 a 80 · Tout sèks · Mizajou Aug 17, 2026 · NCT05305287

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

Ap rekriteFaz 3
  • Research Site, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07664553

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

Ap rekrite
  • Tekton Research, San Antonio
Laj 18 a 75 · Tout sèks · Mizajou Aug 3, 2026 · NCT07521475

SALUD-M: Acceptance Based Coping Skills for Hispanic/Latinx Military Patients With Type 2 Diabetes

Ap rekrite
  • Brooke Army Medical Center, San Antonio
Laj 18 a 70 · Tout sèks · Mizajou Jul 28, 2026 · NCT07674628

SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia

Ap rekriteFaz 1
  • Texas Diabetes Institute/UH, San Antonio
Laj 30 a 75 · Tout sèks · Mizajou Jul 17, 2026 · NCT07053306

SGLTi, Hepatic Glucose Production and Ketogenesis

Ap rekriteFaz 1
  • Texas Diabetes Institute/UH, San Antonio
Laj 30 a 75 · Tout sèks · Mizajou Jul 17, 2026 · NCT05960656

SGLT2i, Hepatic Glucose Production, and SNS

Ap rekriteFaz 1 bonè
  • Texas Diabetes Institute/UH, San Antonio
Laj 30 a 75 · Tout sèks · Mizajou Jul 17, 2026 · NCT07053293

SGLT2i, Pioglitazone, and Ketone Production in T2D

Ap rekriteFaz 1
  • Texas Diabetes Institute/UH, San Antonio
Laj 30 a 75 · Tout sèks · Mizajou Jul 17, 2026 · NCT07053319

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Ap rekriteFaz 2
  • Diabetes & Glandular Disease Clinic, P.A., San Antonio
Laj 18 a 70 · Tout sèks · Mizajou Jun 15, 2026 · NCT07502508

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Ap rekriteFaz 2
  • Tekton Research, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07546929

ROME GS System Study

Ap rekrite
  • Flourish Research - San Antonio, San Antonio
Laj 18 ak plis · Tout sèks · Mizajou Apr 21, 2026 · NCT07518004

Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

Ap rekriteFaz 4
  • University Health - Texas Diabetic Institute, San Antonio
  • University of Texas Health Science Center at San Antonio, San Antonio
Laj 18 a 70 · Tout sèks · Mizajou Apr 13, 2026 · NCT06706284

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

Ap rekriteFaz 3
  • University Health System Texas Diabetic Institute, San Antonio
  • UT Health Science Center, San Antonio
Laj 18 a 75 · Tout sèks · Mizajou Mar 10, 2026 · NCT06246799

Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes

Ap rekriteFaz 1 bonè
  • University of Texas Health Science Center at San Antonio, San Antonio
Laj 18 a 80 · Tout sèks · Mizajou Jan 21, 2026 · NCT06108076

Etid Dyabèt Tip 2 nan lòt vil

Lòt etid nan San Antonio

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.